Shrimp-Derived Antimicrobial Peptide Kills Dangerous Vibrio Bacteria and Boosts Zebrafish Survival to 80%

The peptide was identified from Penaeus vannamei (white shrimp) using ultra-performance liquid chromatography-mass spectrometry and bioinformatics. Antibacterial activity was determined by MIC assays against three Vibrio species. Time-kill kinetics were measured over 2.5 hours. Mechanism studies used fluorescence microscopy to visualize membrane accumulation, membrane integrity assays to detect nucleic acid leakage, and DNA binding assays. In vivo efficacy was tested in zebrafish challenged with V. parahaemolyticus. Safety was assessed by hemolysis and cytotoxicity assays.

Vibrio species are the leading cause of seafood-associated bacterial gastroenteritis worldwide, and V. vulnificus can cause fatal wound infections. Antibiotic resistance in Vibrio is increasing, and conventional antibiotics in aquaculture contribute to resistance development. An antimicrobial peptide derived from the shrimp's own immune system offers a natural, potentially resistance-resistant alternative for both food safety and aquaculture disease prevention — with the added benefit of being nonhemolytic and low-toxicity.

Antimicrobial peptides from marine organisms represent a relatively untapped source of antibiotic candidates. Shrimp have evolved robust innate immune systems to survive in bacteria-rich marine environments, making them a logical source of anti-Vibrio peptides. This study demonstrates the complete pipeline from peptide discovery (mass spectrometry + bioinformatics) through mechanism characterization to in vivo validation — an approach increasingly favored for natural product antibiotic discovery as the antimicrobial resistance crisis intensifies.

The in vivo model used zebrafish rather than a mammalian system, so efficacy in human Vibrio infections cannot be inferred. The MIC against V. vulnificus (125 μg/mL) was substantially higher than against the other two species, suggesting limited activity against this particularly dangerous pathogen. Peptide stability in serum, gastric conditions, and at various temperatures relevant to food preservation was not assessed. Manufacturing scalability and cost were not addressed. Long-term resistance development was not studied.